Most think cervical cancer vaccine should be voluntary
Close to half of all respondents who voted in a poll posted on DrugTopics Web site in May feel that when the cervical cancer vaccineis approved by the FDA, it should be administered on a voluntarybasis, with a warning given to patients that the shot could beassociated with risky sexual behavior. Only 16% feel that thevaccine should be mandatory for girls at puberty to protect thembefore they become sexually active. Another 16% believe the vaccineshould not be mandatory since there are not enough data on thelong-term safety of the product.
Most think cervical cancer vaccine should be voluntary
Close to half of all respondents who voted in a poll posted on Drug Topics Web site in May feel that when the cervical cancer vaccine is approved by the FDA, it should be administered on a voluntary basis, with a warning given to patients that the shot could be associated with risky sexual behavior. Only 16% feel that the vaccine should be mandatory for girls at puberty to protect them before they become sexually active. Another 16% believe the vaccine should not be mandatory since there are not enough data on the long-term safety of the product. Then there are 17% who think that parents should determine whether their daughters are to be vaccinated. Finally 2% said they didn't know how the vaccine should be applied when it is approved. Overall, the poll drew 510 responses.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
